ScinoPharm Taiwan, Ltd. (1789.TW) TAI
Currency In TWD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 13.49B |
| Enterprise Value | 11.15B |
| P/E Ratio | 384.45 |
| PEG Ratio | -4.75 |
| Price/Sales Ratio | 4.72 |
| Price/Book Ratio | 1.52 |
| Enterprise/Revenue | 3.86 |
| Enterprise/EBITDA | 23.1 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0.01 |
| Operating Margin | -0.02 |
AD
Management Effectiveness
| Return On Assets | 0 |
| Return On Equity | 0 |
Income Statement
| Revenue | 3.16B |
| Revenue/Share | 3.53 |
| Gross Profit | 1.1B |
| EBITDA | 673.97M |
| Net Income | 136.95M |
| Diluted EPS | 0.17 |
Balance Sheet
| Total Cash | 3.5B |
| Total Cash/Share | 4.03 |
| Total Debt | 873.09M |
| Total Debt/Equity | 0.08 |
| Current Ratio | 4.74 |
| Book Value Per Share | 12.04 |
Price History
| 52-Week Change | -5.18 |
| 52-Week High | 29.1 |
| 52-Week Low | 16.7 |
| Moving Average 50 Days | 19.41 |
| Moving Average 200 Days | 20.44 |
Statistics
| Average Volume | 651,439 |
| Shares Outstanding | 790.74M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0.29 |
| Trailing Annual Dividend Yield | 1.58 |
| Payout Ratio | 7.34 |
| Last Split Factor | 26:25 |
| Last Split Date | August 10, 2017 |
AD
